Home / PHYOF : OTC

AI Analysis Fundamentals Valuation Video Analysis News Similar

AI Analysis

How does PHYOF make money? Does PHYOF have pricing power? What's the Earnings Whisper? Will PHYOF profit more as the business scales? What is PHYOF's management track record? Is PHYOF's current price justified?

IXICO plc

$0.07 +$0.00 (+0.00%)

OTC · 11 Sep 2026 13:30 UTC

Previous Close

$0.07

Day Range

$0.07 - $0.07

Year Range

$0.07$0.15

Market Cap

6.51M

AVG Volume

430

Trailing/Forward PE

-3.83/-

PEG ratio

0.54

Dividend Yield

Next Earnings Date

2026-12-08

Primary Exchange

Other OTC

Revenue (GBP)

PHYOF Revenue (GBP) by quarter
Period	Revenue (GBP)
26 Q2	3.96M
25 Q4	3.33M
25 Q2	3.21M
24 Q4	3.23M
24 Q2	2.54M
23 Q4	3.46M
23 Q2	3.2M
22 Q4	4.72M
22 Q2	3.92M
21 Q4	4.28M

Net Income (GBP)

PHYOF Net Income (GBP) by quarter
Period	Net Income (GBP)
26 Q2	-1.13M
25 Q4	-693K
25 Q2	-958K
24 Q4	-588K
24 Q2	-1.41M
23 Q4	-453K
23 Q2	-725K
22 Q4	816K
22 Q2	216K
21 Q4	733K

Operating Income (GBP)

PHYOF Operating Income (GBP) by quarter
Period	Operating Income (GBP)
26 Q2	-1.24M
25 Q4	-1.62M
25 Q2	-929K
24 Q4	-1.09M
24 Q2	-1.59M
23 Q4	-728K
23 Q2	-1.09M
22 Q4	436K
22 Q2	-176K
21 Q4	318K

EBITDA (GBP)

PHYOF EBITDA (GBP) by quarter
Period	EBITDA (GBP)
26 Q2	-989.52K
25 Q4	-1.3M
25 Q2	-721K
24 Q4	-302K
24 Q2	-1.35M
23 Q4	-143K
23 Q2	-564K
22 Q4	1.02M
22 Q2	488K
21 Q4	853K

Cash Flows (GBP)

PHYOF Cash Flows (GBP) by quarter
Period	Cash Flows (GBP)
26 Q2	-1.39M
25 Q4	-1.68M
25 Q2	-193K
24 Q4	-540K
24 Q2	-1.2M
23 Q4	-857K
23 Q2	-705K
22 Q4	36K
22 Q2	-851K
21 Q4	-329K

EPS (GBP)

PHYOF EPS (GBP) by quarter
Period	EPS (GBP)
26 Q2	-0.01
25 Q4	-0.01
25 Q2	-0.01
24 Q4	-0.01
24 Q2	-0.03
23 Q4	-0.01
23 Q2	-0.01
22 Q4	0.02
22 Q2	0
21 Q4	0.01

Expenses (GBP)

PHYOF Expenses (GBP) by quarter
Period	Expenses (GBP)
26 Q2	3.38M
25 Q4	3.53M
25 Q2	2.83M
24 Q4	2.66M
24 Q2	2.89M
23 Q4	3.35M
23 Q2	3.28M
22 Q4	3.41M
22 Q2	3.36M
21 Q4	3.63M

Cash & Debt (GBP)

PHYOF Cash & Debt (GBP) by quarter
Period	Cash & Debt (GBP)
26 Q2	1.68M
25 Q4	3.54M
25 Q2	5.01M
24 Q4	1.79M
24 Q2	2.53M
23 Q4	4.03M
23 Q2	5.02M
22 Q4	5.77M
22 Q2	5.8M
21 Q4	6.68M

Debt ratios

PHYOF Debt ratios by quarter
Period	Debt ratios
26 Q2	0.34
25 Q4	0.91
25 Q2	1.88
24 Q4	0.63
24 Q2	2.14
23 Q4	-4.54
23 Q2	-2.51
22 Q4	-1.59
22 Q2	-1.81
21 Q4	-1.97

Margins

PHYOF Margins by quarter
Period	Margins
26 Q2	50.95%
25 Q4	47.9%
25 Q2	49.56%
24 Q4	48.36%
24 Q2	40.19%
23 Q4	45.41%
23 Q2	39.78%
22 Q4	56.64%
22 Q2	54%
21 Q4	63.22%

Return on Capital

PHYOF Return on Capital by quarter
Period	Return on Capital
26 Q2	-10.49%
25 Q4	-5.9%
25 Q2	-7.79%
24 Q4	-6.21%
24 Q2	-14.08%
23 Q4	-3.96%
23 Q2	-6.08%
22 Q4	6.53%
22 Q2	1.87%
21 Q4	6.53%

Shares Outstanding

PHYOF Shares Outstanding by quarter
Period	Shares Outstanding
26 Q2	92.67M
25 Q4	89.47M
25 Q2	86.23M
24 Q4	48.35M
24 Q2	48.35M
23 Q4	48.35M
23 Q2	48.27M
22 Q4	48.15M
22 Q2	48.15M
21 Q4	50.7M

Book Value Per Share (GBP)

PHYOF Book Value Per Share (GBP) by quarter
Period	Book Value Per Share (GBP)
26 Q2	0.12
25 Q4	0.13
25 Q2	0.14
24 Q4	0.2
24 Q2	0.21
23 Q4	0.24
23 Q2	0.25
22 Q4	0.26
22 Q2	0.24
21 Q4	0.22

Total Assets (GBP)

PHYOF Total Assets (GBP) by quarter
Period	Total Assets (GBP)
26 Q2	13.02M
25 Q4	13.84M
25 Q2	14.08M
24 Q4	11.19M
24 Q2	11.57M
23 Q4	12.99M
23 Q2	13.83M
22 Q4	14.65M
22 Q2	13.59M
21 Q4	14.15M

PE Ratio

PHYOF PE Ratio by quarter
Period	PE Ratio
Dec 23	5.48
Dec 23	5.49
Dec 23	7.4
Dec 23	7.3
Nov 23	7.36
Nov 23	7.45
Nov 23	7.59
Nov 23	7.51
Oct 23	7.66
Oct 23	7.63
Oct 23	7.65
Oct 23	7.59
Sep 23	7.61
Sep 23	7.58
Sep 23	7.5
Sep 23	7.44
Sep 23	7.37
Aug 23	7.38
Aug 23	7.29
Aug 23	7.31
Aug 23	7.28
Jul 23	7.23
Jul 23	7.22
Jul 23	7.09
Jul 23	7.23
Jun 23	7.31
Jun 23	2.9
Jun 23	4.32
Jun 23	0.04
Jun 23	0.04
May 23	0.04
May 23	0.04
May 23	0.04
May 23	0.04
Apr 23	0.04
Apr 23	0.04
Apr 23	0.04
Apr 23	2.97
Mar 23	2.99
Mar 23	11.63
Mar 23	11.68
Mar 23	11.82
Mar 23	11.81
Feb 23	11.91
Feb 23	11.81
Feb 23	5.36
Feb 23	5.36
Jan 23	5.21
Jan 23	5.21
Jan 23	5.28
Jan 23	5.35
Dec 22	5.34
Dec 22	6.17
Dec 22	6.12
Dec 22	6.06
Dec 22	6.04
Nov 22	6.15
Nov 22	6.25
Nov 22	6.28
Nov 22	6.53
Oct 22	6.4
Oct 22	6.58
Oct 22	6.65
Oct 22	6.7
Sep 22	6.65
Sep 22	6.84
Sep 22	6.51
Sep 22	9.16
Sep 22	9.21
Aug 22	9.04
Aug 22	8.97
Aug 22	8.75
Aug 22	8.79
Jul 22	8.72
Jul 22	8.84
Jul 22	8.94
Jul 22	8.82
Jul 22	8.77
Jun 22	8.18
Jun 22	6.89
Jun 22	6.85
Jun 22	6.75
May 22	6.67
May 22	6.74
May 22	6.88
May 22	6.83
Apr 22	6.7
Apr 22	6.25
Apr 22	7.98
Apr 22	8
Apr 22	7.96
Mar 22	7.91
Mar 22	7.92
Mar 22	8
Mar 22	8.34
Feb 22	8.97
Feb 22	11.37
Feb 22	11.39
Feb 22	11.42
Jan 22	11.53

Free Cash Flow Yield

PHYOF Free Cash Flow Yield by quarter
Period	Free Cash Flow Yield
Sep 26	-79.44%
Sep 26	-79.34%
Aug 26	-79.44%
Aug 26	-80.08%
Aug 26	-79.44%
Aug 26	-79.18%
Jul 26	-79.11%
Jul 26	-78.16%
Jul 26	-78.96%
Jul 26	-78.63%
Jul 26	-78.34%
Jun 26	-76.12%
Jun 26	-76.19%
Jun 26	-77.32%
Jun 26	-76.94%
May 26	-77.61%
May 26	-77.48%
May 26	-76.85%
May 26	-78.63%
May 26	-78.29%
Apr 26	-78.05%
Apr 26	-77.95%
Apr 26	-77.64%
Apr 26	-76.27%
Mar 26	-76.49%
Mar 26	-76.97%
Mar 26	-76.15%
Mar 26	-77.36%
Feb 26	-77.77%
Feb 26	-77.75%
Feb 26	-78.76%
Feb 26	-78.52%
Jan 26	-78.93%
Jan 26	-78.7%
Jan 26	-77.16%
Jan 26	-77.31%
Jan 26	-77.62%
Dec 25	-62.29%
Dec 25	-61.72%
Dec 25	-61.7%
Dec 25	-61.51%
Nov 25	-61.07%
Nov 25	-60.44%
Nov 25	-60.79%
Nov 25	-60.74%
Oct 25	-60.48%
Oct 25	-61.42%
Oct 25	-61.94%
Oct 25	-61.63%
Oct 25	-62.19%
Sep 25	-61.83%
Sep 25	-62.17%
Sep 25	-62.6%
Sep 25	-62.32%
Aug 25	-62.31%
Aug 25	-62.38%
Aug 25	-62.54%
Aug 25	-62.07%
Aug 25	-61.26%
Jul 25	-62.01%
Jul 25	-61.93%
Jul 25	-62.25%
Jul 25	-63%
Jun 25	-133.61%
Jun 25	-131.01%
Jun 25	-132.21%
Jun 25	-131.77%
May 25	-131.06%
May 25	-131.87%
May 25	-129.39%
May 25	-129.57%
May 25	-129.25%
Apr 25	-129.69%
Apr 25	-129.22%
Apr 25	-127.47%
Apr 25	-125.57%
Mar 25	-125.92%
Mar 25	-125.8%
Mar 25	-126.03%
Mar 25	-125.87%
Feb 25	-122.52%
Feb 25	-123.02%
Feb 25	-122.62%
Feb 25	-120.81%
Jan 25	-120.72%
Jan 25	-121.59%
Jan 25	-118.55%
Jan 25	-118.94%
Jan 25	-121.01%
Dec 24	-101.14%
Dec 24	-100.99%
Dec 24	-101.46%
Dec 24	-102.45%
Nov 24	-102.4%
Nov 24	-100.74%
Nov 24	-101.46%
Nov 24	-103.88%
Nov 24	-103.87%
Oct 24	-104.19%
Oct 24	-104.92%

Price to Sales

PHYOF Price to Sales by quarter
Period	Price to Sales
Sep 26	0.35
Sep 26	0.35
Aug 26	0.35
Aug 26	0.35
Aug 26	0.35
Aug 26	0.35
Jul 26	0.35
Jul 26	0.35
Jul 26	0.35
Jul 26	0.35
Jul 26	0.35
Jun 26	0.39
Jun 26	0.39
Jun 26	0.38
Jun 26	0.38
May 26	0.38
May 26	0.38
May 26	0.38
May 26	0.37
May 26	0.38
Apr 26	0.38
Apr 26	0.38
Apr 26	0.38
Apr 26	0.39
Mar 26	0.38
Mar 26	0.38
Mar 26	0.39
Mar 26	0.38
Feb 26	0.38
Feb 26	0.38
Feb 26	0.37
Feb 26	0.37
Jan 26	0.37
Jan 26	0.37
Jan 26	0.38
Jan 26	0.38
Jan 26	0.38
Dec 25	0.36
Dec 25	0.36
Dec 25	0.36
Dec 25	0.36
Nov 25	0.37
Nov 25	0.37
Nov 25	0.37
Nov 25	0.37
Oct 25	0.37
Oct 25	0.36
Oct 25	0.36
Oct 25	0.36
Oct 25	0.36
Sep 25	0.36
Sep 25	0.36
Sep 25	0.36
Sep 25	0.36
Aug 25	0.36
Aug 25	0.36
Aug 25	0.36
Aug 25	0.36
Aug 25	0.37
Jul 25	0.36
Jul 25	0.36
Jul 25	0.36
Jul 25	0.36
Jun 25	0.2
Jun 25	0.2
Jun 25	0.2
Jun 25	0.2
May 25	0.2
May 25	0.2
May 25	0.2
May 25	0.2
May 25	0.21
Apr 25	0.2
Apr 25	0.21
Apr 25	0.21
Apr 25	0.21
Mar 25	0.21
Mar 25	0.21
Mar 25	0.21
Mar 25	0.21
Feb 25	0.22
Feb 25	0.22
Feb 25	0.22
Feb 25	0.22
Jan 25	0.22
Jan 25	0.22
Jan 25	0.22
Jan 25	0.22
Jan 25	0.22
Dec 24	0.19
Dec 24	0.19
Dec 24	0.19
Dec 24	0.19
Nov 24	0.19
Nov 24	0.19
Nov 24	0.19
Nov 24	0.19
Nov 24	0.19
Oct 24	0.19
Oct 24	0.19

EV/EBITDA

PHYOF EV/EBITDA by quarter
Period	EV/EBITDA
Jun 24	2.61
Jun 24	2.61
Jun 24	2.58
Jun 24	2.56
May 24	2.55
May 24	2.56
May 24	2.58
May 24	2.68
May 24	2.66
Apr 24	2.69
Apr 24	2.77
Apr 24	2.72
Apr 24	2.61
Mar 24	2.62
Mar 24	2.63
Mar 24	2.56
Mar 24	2.49
Mar 24	2.6
Feb 24	2.59
Feb 24	2.63
Feb 24	2.62
Feb 24	2.62
Jan 24	2.58
Jan 24	2.57
Jan 24	2.55
Jan 24	2.57
Dec 23	2.56
Dec 23	0.66
Dec 23	0.67
Dec 23	1.77
Dec 23	1.71
Nov 23	1.75
Nov 23	1.8
Nov 23	1.88
Nov 23	1.83
Oct 23	1.92
Oct 23	1.9
Oct 23	1.91
Oct 23	1.88
Sep 23	1.89
Sep 23	1.88
Sep 23	1.82
Sep 23	1.8
Sep 23	1.75
Aug 23	1.76
Aug 23	1.71
Aug 23	1.72
Aug 23	1.7
Jul 23	1.67
Jul 23	1.67
Jul 23	1.59
Jul 23	1.67
Jun 23	1.72
Jun 23	0.7
Jun 23	1.82
Jun 23	-1.56
Jun 23	-1.56
May 23	-1.56
May 23	-1.56
May 23	-1.56
May 23	-1.56
Apr 23	-1.56
Apr 23	-1.56
Apr 23	-1.56
Apr 23	0.75
Mar 23	0.77
Mar 23	7.6
Mar 23	7.64
Mar 23	7.75
Mar 23	7.74
Feb 23	7.82
Feb 23	7.74
Feb 23	2.64
Feb 23	2.65
Jan 23	2.53
Jan 23	2.53
Jan 23	2.58
Jan 23	2.63
Dec 22	2.63
Dec 22	3.01
Dec 22	2.97
Dec 22	2.93
Dec 22	2.92
Nov 22	3
Nov 22	3.08
Nov 22	3.1
Nov 22	3.3
Oct 22	3.19
Oct 22	3.33
Oct 22	3.39
Oct 22	3.43
Sep 22	3.39
Sep 22	3.54
Sep 22	3.28
Sep 22	5.35
Sep 22	5.39
Aug 22	5.26
Aug 22	5.21
Aug 22	5.03
Aug 22	5.07

Price/Operating Cashflow

PHYOF Price/Operating Cashflow by quarter
Period	Price/Operating Cashflow
Dec 24	6.09
Dec 24	6.1
Dec 24	6.07
Dec 24	6.01
Nov 24	6.01
Nov 24	6.11
Nov 24	6.07
Nov 24	5.93
Nov 24	5.93
Oct 24	5.91
Oct 24	5.87
Oct 24	5.86
Oct 24	5.83
Sep 24	5.73
Sep 24	5.75
Sep 24	5.83
Sep 24	5.83
Aug 24	5.83
Aug 24	5.79
Aug 24	5.91
Aug 24	6
Aug 24	5.98
Jul 24	5.95
Jul 24	12.71
Jul 24	12.63
Jul 24	12.81
Jun 24	3.13
Jun 24	3.13
Jun 24	3.12
Jun 24	3.11
May 24	3.11
May 24	3.11
May 24	3.12
May 24	3.16
May 24	3.16
Apr 24	3.17
Apr 24	3.2
Apr 24	3.18
Apr 24	3.13
Mar 24	3.14
Mar 24	3.14
Mar 24	3.11
Mar 24	3.08
Mar 24	3.13
Feb 24	3.13
Feb 24	3.14
Feb 24	3.14
Feb 24	3.14
Jan 24	3.12
Jan 24	3.12
Jan 24	3.11
Jan 24	3.11
Dec 23	3.11
Dec 23	2.23
Dec 23	2.24
Dec 23	3.01
Dec 23	2.97
Nov 23	3
Nov 23	3.03
Nov 23	3.09
Nov 23	3.06
Oct 23	3.12
Oct 23	3.11
Oct 23	3.11
Oct 23	3.09
Sep 23	3.1
Sep 23	3.09
Sep 23	3.05
Sep 23	3.03
Sep 23	3
Aug 23	3
Aug 23	2.97
Aug 23	2.98
Aug 23	2.97
Jul 23	2.94
Jul 23	2.94
Jul 23	2.89
Jul 23	2.94
Jun 23	2.98
Jun 23	3.7
Jun 23	5.51
Jun 23	0.06
Jun 23	0.06
May 23	0.06
May 23	0.06
May 23	0.06
May 23	0.06
Apr 23	0.06
Apr 23	0.06
Apr 23	0.06
Apr 23	3.79
Mar 23	3.82
Mar 23	14.83
Mar 23	14.9
Mar 23	15.07
Mar 23	15.06
Feb 23	15.19
Feb 23	15.06
Feb 23	6.84
Feb 23	6.84

Price to Book

PHYOF Price to Book by quarter
Period	Price to Book
Sep 26	0.45
Sep 26	0.45
Aug 26	0.45
Aug 26	0.44
Aug 26	0.45
Aug 26	0.45
Jul 26	0.45
Jul 26	0.45
Jul 26	0.45
Jul 26	0.45
Jul 26	0.45
Jun 26	0.4
Jun 26	0.4
Jun 26	0.4
Jun 26	0.4
May 26	0.4
May 26	0.4
May 26	0.4
May 26	0.39
May 26	0.39
Apr 26	0.39
Apr 26	0.39
Apr 26	0.4
Apr 26	0.4
Mar 26	0.4
Mar 26	0.4
Mar 26	0.4
Mar 26	0.4
Feb 26	0.4
Feb 26	0.4
Feb 26	0.39
Feb 26	0.39
Jan 26	0.39
Jan 26	0.39
Jan 26	0.4
Jan 26	0.4
Jan 26	0.4
Dec 25	0.36
Dec 25	0.37
Dec 25	0.37
Dec 25	0.37
Nov 25	0.37
Nov 25	0.37
Nov 25	0.37
Nov 25	0.37
Oct 25	0.37
Oct 25	0.37
Oct 25	0.37
Oct 25	0.37
Oct 25	0.36
Sep 25	0.37
Sep 25	0.36
Sep 25	0.36
Sep 25	0.36
Aug 25	0.36
Aug 25	0.36
Aug 25	0.36
Aug 25	0.37
Aug 25	0.37
Jul 25	0.37
Jul 25	0.37
Jul 25	0.36
Jul 25	0.36
Jun 25	0.26
Jun 25	0.27
Jun 25	0.26
Jun 25	0.26
May 25	0.27
May 25	0.26
May 25	0.27
May 25	0.27
May 25	0.27
Apr 25	0.27
Apr 25	0.27
Apr 25	0.27
Apr 25	0.28
Mar 25	0.28
Mar 25	0.28
Mar 25	0.28
Mar 25	0.28
Feb 25	0.28
Feb 25	0.28
Feb 25	0.28
Feb 25	0.29
Jan 25	0.29
Jan 25	0.29
Jan 25	0.29
Jan 25	0.29
Jan 25	0.29
Dec 24	0.27
Dec 24	0.27
Dec 24	0.27
Dec 24	0.26
Nov 24	0.26
Nov 24	0.27
Nov 24	0.27
Nov 24	0.26
Nov 24	0.26
Oct 24	0.26
Oct 24	0.26

No video analysis for this stock yet. Request one from our team.

News: PHYOF

proactiveinvestors.com · 13 Jul 2026

IXICO guidance unchanged after Huntington's cancellations

IXICO PLC (LSE:IXI, OTC:PHYOF, FRA:PYPB), a neuroscience imaging and biomarker analytics company, has confirmed its revenue guidance remains unchanged after...

proactiveinvestors.co.uk · 13 Jul 2026

IXICO guidance unchanged after Huntington's cancellations

IXICO PLC (LSE:IXI, OTC:PHYOF, FRA:PYPB), a neuroscience imaging and biomarker analytics company, has confirmed its revenue guidance remains unchanged after two clients discontinued Huntington's disease programmes it was supporting. The AIM-listed company said the cancellations would reduce its contracted order book by around £1.5 million over the next two financial years.

proactiveinvestors.com · 8 Jul 2026

South32’s $4.7bn Hermosa project clears key US approval as critical minerals push accelerates

South32 Ltd (LSE:S32, ASX:S32, FRA:32Z, OTC:SHTLF, JSE:S32) has secured a major US federal approval for its US$4.7 billion Hermosa critical minerals project...

proactiveinvestors.com · 7 Jul 2026

IXICO lifts revenue forecast on contract wins and wider client base - UPDATE

Shares in IXICO PLC (LSE:IXI, OTC:PHYOF, FRA:PYPB), the neuroscience imaging company, rose 11% to 9p after it has raised its revenue forecast for the...

proactiveinvestors.co.uk · 7 Jul 2026

IXICO lifts revenue forecast on contract wins and wider client base

IXICO PLC (LSE:IXI, OTC:PHYOF, FRA:PYPB), the neuroscience imaging company, has raised its revenue forecast for the current financial year after stronger-than-expected trading. The company now expects revenues of at least £8 million for the year ending 30 September 2026.

AI Analysis

IXICO plc

Video analysis: PHYOF

News: PHYOF

IXICO guidance unchanged after Huntington's cancellations

IXICO guidance unchanged after Huntington's cancellations

South32’s $4.7bn Hermosa project clears key US approval as critical minerals push accelerates

IXICO lifts revenue forecast on contract wins and wider client base - UPDATE

IXICO lifts revenue forecast on contract wins and wider client base

Similar companies